3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Pancreatic Neoplasms
8
Ovarian Neoplasms
5
Mesothelioma, Malignant
4
Carcinoma, Non-Small-Cell Lung
4
Lung Neoplasms
3
Uterine Cervical Neoplasms
2
Thyroid Neoplasms
2
Stomach Neoplasms
2
Neoplasms
2
Mesothelioma
2
Melanoma
2
Glioblastoma
2
Uveal Melanoma
1
Uterine Neoplasms
1
Urinary Bladder Neoplasms
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Phase IB
1
Non Hematologic Cancers
1
Neoplasms, Mesothelial
1
Neoplasm Metastasis
1
Myelodysplastic Syndromes
1
Multiple Myeloma
1
Mesonephric Gynecologic Cancer
1
Lymphoma
1
Low-Grade Serous Ovarian Cancer
1
Low Grade Serous Ovarian Cancer
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid, Acute
1
Hematologic Neoplasms
1
Interventions
defactinib
1
Letrozole
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Low-Grade Serous Ovarian Cancer
×
defactinib
×
Clear all
NCT06394804
2026-04-23
CHAMELEON
Memorial Sloan Kettering Cancer Center
Phase 2
Recruiting
20 enrolled